Eli Lilly and Company ( NYSE: LLY ) 5th Annual Evercore ISI HealthCONx Conference 2022 Conference Call November 30, 2022 12:10 PM ET Company Participants Jacob Van Naarden - Executive Vice President and Chief Executive Officer, Loxo@Lilly David Hyman - Chief Medical Officer, Loxo@Lilly Joe Fletcher - SVP, IR Conference Call Participants Umer Raffat - Evercore ISI Umer Raffat Excellent. Thank you, guys for joining us. It's a pleasure to have Eli Lilly management join us. There's a lot to talk about, but before we do, let me turn it over to Jake to kick things off. Jacob Van Naarden Sure. I'm Jake Van Naarden and I lead the oncology unit here at Lilly. And thanks to the Evercore ISI team for having us today.